Site 14
Site 14
Spokane, Washington, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis | Moderate-to-severe Chronic Plaque Psoriasis | Active, not recruiting | Phase 2 / Phase 3 | 2026-04-15 | NCT03997786 |